136 related articles for article (PubMed ID: 11956108)
1. Identification of nuclear matrix protein alterations associated with human colon cancer.
Brünagel G; Vietmeier BN; Bauer AJ; Schoen RE; Getzenberg RH
Cancer Res; 2002 Apr; 62(8):2437-42. PubMed ID: 11956108
[TBL] [Abstract][Full Text] [Related]
2. Identification of calreticulin as a nuclear matrix protein associated with human colon cancer.
Brünagel G; Shah U; Schoen RE; Getzenberg RH
J Cell Biochem; 2003 May; 89(2):238-43. PubMed ID: 12704787
[TBL] [Abstract][Full Text] [Related]
3. Colon cancer specific nuclear matrix protein alterations in human colonic adenomatous polyps.
Brünagel G; Schoen RE; Getzenberg RH
J Cell Biochem; 2004 Feb; 91(2):365-74. PubMed ID: 14743395
[TBL] [Abstract][Full Text] [Related]
4. The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer.
Walgenbach-Brunagel G; Burger B; Leman ES; Walgenbach KJ; Tolba R; Heukamp L; Hirner A; Getzenberg RH
J Cell Biochem; 2008 May; 104(1):286-94. PubMed ID: 18044711
[TBL] [Abstract][Full Text] [Related]
5. Nuclear matrix protein alterations associated with colon cancer metastasis to the liver.
Brünagel G; Schoen RE; Bauer AJ; Vietmeier BN; Getzenberg RH
Clin Cancer Res; 2002 Oct; 8(10):3039-45. PubMed ID: 12374670
[TBL] [Abstract][Full Text] [Related]
6. Bladder cancer-associated nuclear matrix proteins.
Getzenberg RH; Konety BR; Oeler TA; Quigley MM; Hakam A; Becich MJ; Bahnson RR
Cancer Res; 1996 Apr; 56(7):1690-4. PubMed ID: 8603421
[TBL] [Abstract][Full Text] [Related]
7. Identification of nuclear matrix protein alterations associated with renal cell carcinoma.
Konety BR; Nangia AK; Nguyen TS; Veitmeier BN; Dhir R; Acierno JS; Becich MJ; Hrebinko RL; Getzenberg RH
J Urol; 1998 Apr; 159(4):1359-63. PubMed ID: 9507884
[TBL] [Abstract][Full Text] [Related]
8. Two-dimensional electrophoretic analysis of nuclear matrix proteins in human colon adenocarcinoma.
Toumpanaki A; Baltatzis GE; Gaitanarou E; Seretis E; Toumpanakis C; Aroni K; Kittas C; Voloudakis-Baltatzis IE
Ultrastruct Pathol; 2009; 33(2):83-91. PubMed ID: 19274585
[TBL] [Abstract][Full Text] [Related]
9. Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer.
Balasubramani M; Day BW; Schoen RE; Getzenberg RH
Cancer Res; 2006 Jan; 66(2):763-9. PubMed ID: 16424007
[TBL] [Abstract][Full Text] [Related]
10. Nuclear matrix proteins in well and poorly differentiated human breast cancer cell lines.
Samuel SK; Minish TM; Davie JR
J Cell Biochem; 1997 Jul; 66(1):9-15. PubMed ID: 9215523
[TBL] [Abstract][Full Text] [Related]
11. Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4.
Konety BR; Nguyen TS; Dhir R; Day RS; Becich MJ; Stadler WM; Getzenberg RH
Clin Cancer Res; 2000 Jul; 6(7):2618-25. PubMed ID: 10914702
[TBL] [Abstract][Full Text] [Related]
12. Differential nuclear matrix protein expression in prostate cancers: correlation with pathologic stage.
Lakshmanan Y; Subong EN; Partin AW
J Urol; 1998 Apr; 159(4):1354-8. PubMed ID: 9507883
[TBL] [Abstract][Full Text] [Related]
13. Galanin is up-regulated in colon adenocarcinoma.
Kim KY; Kee MK; Chong SA; Nam MJ
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2373-8. PubMed ID: 18006926
[TBL] [Abstract][Full Text] [Related]
14. Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins.
Partin AW; Briggman JV; Subong EN; Szaro R; Oreper A; Wiesbrock S; Meyer J; Coffey DS; Epstein JI
Urology; 1997 Nov; 50(5):800-8. PubMed ID: 9372899
[TBL] [Abstract][Full Text] [Related]
15. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer.
Partin AW; Getzenberg RH; CarMichael MJ; Vindivich D; Yoo J; Epstein JI; Coffey DS
Cancer Res; 1993 Feb; 53(4):744-6. PubMed ID: 7679049
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
17. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.
Roessler M; Rollinger W; Palme S; Hagmann ML; Berndt P; Engel AM; Schneidinger B; Pfeffer M; Andres H; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
Clin Cancer Res; 2005 Sep; 11(18):6550-7. PubMed ID: 16166432
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
19. Search for epithelial-specific mRNAs in peripheral blood of patients with colon cancer by RT-PCR.
Solmi R; De Sanctis P; Zucchini C; Ugolini G; Rosati G; Del Governatore M; Coppola D; Yeatman TJ; Lenzi L; Caira A; Zanotti S; Taffurelli M; Carinci P; Valvassori L; Strippoli P
Int J Oncol; 2004 Oct; 25(4):1049-56. PubMed ID: 15375555
[TBL] [Abstract][Full Text] [Related]
20. [Differential analysis of two-dimension gel electrophoresis profiles of human lung squamous carcinoma and tumor-adjacent tissue].
Li C; Chen ZC; Xiao ZQ; Wu XY; Zhan XQ; Li MY; Feng XP; Zhang XP; Li JL; Chen P; Liang SP
Ai Zheng; 2004 Jan; 23(1):28-35. PubMed ID: 14720370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
